March Altus Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-17,386	Closed	-$692K	–	12
2015 Q3	$692K	Buy	17,386 +8,793	+102%	+$350K	4.08%	12
2015 Q2	$410K	Buy	+8,593	New	+$410K	2.38%	17